Oxford Nanopore’s $35M Mystery Dx Cross-Licensing Deal: Newsletter Aug. 19, 2026

Nucleai and Gilead team up on ADCs, Natera partners with Germany’s Kupando, Freenome gets FDA breakthrough designation, a new FDA commish nominee, and more.